Hotels Are Staffing Robots—and Guests Are Freaking Out► https://t.co/ArCQxFh0Te https://t.co/ArCQxFh0Te ...

X is piloting a program that lets AI chatbots generate Community Notes | TechCrunch https://t.co/kbOuWEaHvI ...

At the moment Ukraine is winning the race against Russia to develop military robots—largely because it has to. While its machines are yet to appear on the battlefield in large numbers, their moment may be near https://t.co/5nnawioVlf ...

Optimus will blow your mind. AI powered steps toward a future where robots transform work and exploration. https://t.co/LCnJVn24Nb ...

🚨 William Blair says Tesla could tap a $250B Robotaxi goldmineWith Austin rollout underway, $TSLA may grab 1/3 of the $1.4T market by 2040, leaving $UBER behind.Blair values Robotaxi alone at $300/share.Bumps ahead? Yes. But the upside? MASSIVE. 🔥Link: https://t.co/VkfdtHNOwC ...

Genesis AI launches with $105M seed funding from Eclipse, Khosla to build AI models for robots | TechCrunch https://t.co/8Eszsa6ppd ...

Core Insights - Stereotaxis has published initial clinical results of the MAGiC catheter in a peer-reviewed journal, demonstrating its efficacy and safety for minimally invasive endovascular interventions [1][2]. Company Overview - Stereotaxis is a pioneer in surgical robotics for minimally invasive endovascular interventions, with a mission to develop robotic systems and solutions that enhance patient care and operating room efficiency [6]. Clinical Study Details - The study involved a prospective multi-center, single-arm design, treating 67 patients with various arrhythmias, including atrial fibrillation and ventricular tachycardia, with ongoing enrollment expected to reach around 100 patients [2][3]. - The acute efficacy of the MAGiC catheter was reported at 94%, with an average procedure time of 83 minutes and a procedure-related adverse event rate of 1.5% [3]. Product Features - The MAGiC catheter is designed for cardiac ablation procedures, enhancing treatment precision and control while maintaining safety through its soft flexible design [4]. - The catheter has shown improved stability, not requiring sheaths for support, and maintaining steady temperatures during ablation, which benefits patients with compromised cardiac and renal function [3][4]. Market Presence - Stereotaxis' robotic technologies have been utilized in over 100 leading hospitals globally, treating more than 150,000 patients [4].

NORWELL, Mass., and ZÜRICH, Switzerland, July 01, 2025 (GLOBE NEWSWIRE) -- DIH HOLDING US, Inc. (“DIH”) (NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Rehazentrum Valens, a member of the Kliniken Valens ...

Core Points - EDAP TMS SA will transition to U.S. reporting status effective January 1, 2026, ceasing to qualify as a foreign private issuer under SEC rules [1] - This change reflects the company's commitment to transparency and regulatory best practices, aiming to strengthen relationships with shareholders and attract institutional investors [2] Company Overview - EDAP TMS SA is a leader in robotic energy-based therapies, developing and distributing minimally invasive medical devices using ultrasound technology [2] - The company has introduced the Focal One® system, a leading prostate focal therapy, with potential applications beyond prostate cancer [2]

Cloudflare launches a marketplace that lets websites charge AI bots for scraping | TechCrunch https://t.co/ndMzySGrkM ...